Thursday May 25th 2017

Archive for July, 2011

CCSVI Society Not Impressed With Observational Study

CCSVI Society Not Impressed With Observational Study

The Grande Prairie CCSVI Society isn’t happy with the government’s move to start up an MS observational study. President Debbie Golden says the government should be moving to clinical trials to see if the CCSVI treatment is good to go in Alberta. Golden says the [Read More]

Internet study to track liberation treatment for MS patients

Internet study to track liberation treatment for MS patients

Albertans with multiple sclerosis, including those who have had the so-called “liberation” treatment to open blocked veins, are being encouraged to document their experiences online as part of a provincewide university-led study to see how both groups fare. Many of [Read More]

Alberta to announce next step in MS Initiative

Alberta to announce next step in MS Initiative

On Wednesday, Alberta’s health minister is set to outline the next step in the Alberta MS Initiative (TAMSI). CTV News has learned the initiative will include a website and an online questionnaire. Up until this point, many Canadian MS patients have been opted to [Read More]

 Page 1 of 11  1  2  3  4  5 » ...  Last » 

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]